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Abstract. Adverse Drug Reaction (ADR) has become a central concern for many 
healthcare providers [15]. It is well-known that adverse reactions to drugs are a rea-
son for several health problems. According to the Food and Drug Administration 
(FDA) estimation, ADRs are the 4th leading cause of death [15]. The prevalence of 
ADRs necessitates the establishment of a simple ADR reporting process. The ADR 
reporting process involves many stakeholders such as the FDA, the patient, and the 
health professional. The research uncovered a significant lack of communication 
among the stakeholders, thus the research goal is to improve this lack in communica-
tion. This research focuses on how to improve ADR reporting based on patients’ posts 
on Twitter and also what solution can be provided to improve the communication 
between the patient and the doctor during the ADR reporting process. Therefore, this 
study proposes a solution to enhance such the communication between the stakehold-
ers. 
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1 Introduction  
 As Adverse Drug Reactions (ADRs) are considered one of the leading causes of 
death in health care [15]. Medical researchers have become increasingly interested in 
studying ADR due to its importance as a significant public health problem that can be 
prevented [15]. In fact, Sloane stated that ADRs are considered one of the main causes 
of illness, hospitalization, and mortality [10]. As a consequence, the drug reactions 
have received a considerable amount of attention by drug scientists and health profes-
sionals.  
 
Recently, a study found that 42% of the patients involved in social networks discuss 
their current health conditions online [18]. Thus, social networks become a potential 
vital source of information to monitor the effects of medical drugs after they have 
been licensed [10], yet there are different issues when it comes to report an ADR from 
online data sources. One issue is that patients post their drug reactions on different 
social networks, such as Twitter, which does not necessarily mean their doctors will 
receive it. Another issue is that there are criteria that need to be fulfilled in order for 
the report to be recognized by the Food and Drug Administration (FDA) [9].  
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The propose solution addresses three objectives. The first objective is to provide a 
reliable solution that works as a communication channel between patients and health 
professionals. A second objective is to provide a solution that help the patient to report 
ADRs to their health professionals. A third objective is to provide a solution for health 
professionals to report ADRs through Twitter while taking into consideration the FDA 
criteria. The research questions focus on how the (ADR) reporting can be improved 
based on patients’ posts on Twitter and also what solution can be provided to improve 
the communication between the patient and the primary doctor during the ADR re-
porting process. This study provides a reliable tool called an Easy Reporting (EZ-R) 
that will allow users to report ADRs and aims to enhance such communication, which 
will eventually benefit all involved stakeholders. To enhance a rich communication 
among stakeholders during the reporting process, this study draws upon Media Rich-
ness Theory (MRT) [13]. Section 3, explain the MRT as the theoretical foundation for 
the propose solution. 
2 Background and Related Work 
An Adverse Drug Reaction is defined as any serious undesirable experience that a 
patient has associated with the use of a medical product [2]. ADRs make around 30% 
of hospital admissions in the US and costs up to 30.1 billion dollars per year [16]. 
ADRs can occur to any number of patients after a drug enters the market. This led to 
the establishment of the ADR reporting processes. 
 
The current ADR process has a few limitations. The ADR process involves many 
stakeholders, two of which must be present to complete a report. The FDA is one 
stakeholder and they are responsible for protecting the public health, investigating 
drug complaints, and monitoring drug reactions [12]. Either the patient or the doctor 
may submit an ADR to the FDA. Moreover, a new study found that 86 % of Adverse 
Events (AEs) went unreported [17]. Even if a patient files an online complaint, the 
process often poses a big challenge because the current online process has many lim-
itations; according to Ying et. al. [8].  One of those limitations is the dependence on 
volunteers to report ADRs. This makes it a passive system that is limited by latency 
and inconsistency, which resulted a significant lack of communication between 
healthcare providers and patients. Therefore, a solution is needed in order to prevent 
more ADR related to deaths and costs for the country. 
 
Today, patients are increasingly turning to social networks as a source for health-
related information, health and wellness advice, and to share experiences [1]. Accord-
ing to a recent study, 26% of adult that use Internet discuss their personal health prob-
lems online and 42% of them discussing current conditions on social network [18]. 
Twitter, one of the most popular social network websites, has around 320 million users 
monthly as of December 31, 2015 [14]. According to Ginn, R., et. al., [5], Twitter 
users generate more than 9000 tweets every 4 seconds. With this volume of data, 
healthcare providers and agencies tried to analyzing and predicting ADRs from the 
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content of Twitter using data mining techniques [10]. Yet, this approach lack the FDA 
four criteria as a requirement to accept ADR reports based on social network data 
mining, specifically: 1. An identifiable patient which is the patient information that 
includes patient name, or patient identification number; 2. An identifiable reporter 
which is the person who is in charge of reporting to the FDA such as a family member, 
doctor, or pharmacist; 3. The drug name that causes the ADR; 4. An adverse event or 
fatal outcome that caused by the drug [4].  
3 Theoretical Foundation 
The theoretical foundation of this study draws upon Media Richness Theory 
(MRT), developed by Richard L. Daft and Robert H. Lengel in the 1980’s [13]. MRT 
categorized different levels of communication media to carry information, ranging 
from low (or lean) richness to high (or full) richness [13]. For instance, within a hos-
pital setting, a lower level communication media channel between doctor and patient 
would be letters, reports, and emails, while a higher richness level of communication 
that provides rapid response and feedback channels are vehicles such as face-to-face 
communications and videoconferencing [13]. 
The MRT provides a theoretical basis for the propose tool (EZ-R). In fact, in this 
study, the MRT inspired the researchers to build an artifact considering the commu-
nication aspect between the doctor and the patient. Such an artifact that will mediate 
the ADR reporting process and improve the current passive low richness method into 
a richer, and more active method. It also facilitates more instant feedback between the 
patient and the health professional. Therefore, MRT grounded this research and in-
spired the design process in applying features such as chat feature (instant messaging) 
and other features that allow bi-directionally real-time communication between the 
two parties to facilitate an immediate feedback capability.  
4 Research Approach   
This research follows the Design Science Research (DSR) approach, introduced by 
Hevner and Chatterjee [7], which includes a set of artifacts that solves a wicked prob-
lem. DSR is composed of three related cycles: “the relevance cycle, the rigor cycle, 
and the design cycle” [7]. The relevance cycle utilization is to connect the require-
ments from the environment related to the research. The rigor cycle provides the prior 
knowledge as a foundation to the research as well as helps to add a new knowledge 
from the research to the knowledge base. The design cycle contributes as the construc-
tion and evaluation phase of the artifacts. Moreover, the DSR artifact outcome can be 
one or more namely, constructs which include vocabulary and symbols; models which 
include abstractions or representations; methods which include algorithms or prac-
tices; instantiations which include implemented or prototype systems; or design better 
theories [7].  
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Therefore, based on the DSR approach, the goal of this research is to define the 
problem and develop an artifact that can provides a reliable solution as a communica-
tion channel between patients and health professionals, and ultimately improve ADR 
reporting. Thus, the outcome solution consists of three main artifacts: a patient mobile 
application (instantiation), a doctor mobile application (instantiation), and an algo-
rithm (method) that run in the backend of both applications. 
5 Designing & Building the Artifacts 
5.1 Technical Requirements 
To develop the applications, android studio was used to implement both doctor and 
patient applications. The following tools were used during the development phase: 
android Software Development Kit (SDK), Java, Android Mobile OS, Twitter API, 
MySQL database, and JSON (JavaScript Object Notation). 
5.2 Design & Build the Artifacts 
From DSR perspectives, each of the artifacts designed to play a different role in 
reporting ADR namely, Dashboard (doctor’s application), Mobile Application (pa-
tient's application), and an algorithm to looks up and detects side effects in patient 
tweets (both patients and doctor applications). The three artifacts have been designed 
and developed in iteration process. Both applications and algorithm have been con-
structed and tested to build the final artifacts. The source of the data was from 
Drugs.com and collected based on the top 20 drug names and the relevant 700 side 
effect terms, that being looked up on searches engines. This collected data have been 
stored on databased on the server. This sample have been used to test both applications 
and algorithm functionality.   
 
The EZ-R works under two assumptions. First, the research team assumes that the 
doctor has a list of patients’ Twitter usernames. Another assumption is that the patient 
agreed that all of their tweets will be monitored by the doctor. Each doctor will have 
an application that works as a dashboard. The next sections will describe both appli-
cations in detail. 
5.3 Artifact 1: Doctor Dashboard Application (Instantiation) 
In this dashboard, the home page contains the main functions which are “View 
Report”, “Lookup for Patient on Twitter”, “Chat with Patient”, and “Send SMS to 
Patient”. These functions empower doctors to help their patients to report the side 
effects. With taking into consideration of the previous assumptions, the doctor will 
use the “lookup for patients” function, which runs the algorithm to find out whether 
or not the patient’s tweets contain mention of side effects. If the algorithm found that 
the patient’s tweets contain a side effect, then the doctor’s screen will shows this side 
effect. Next, the doctor can initially use “Send SMS” function to send an SMS to the 
patient to download the patient application on his/her smartphone. After the patient 
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downloads the application, then the doctor will be able to use the following functions: 
the “View Report” function shows a list of reports or questions that are submitted by 
the patient. The “Chat with Patient” function enables the patient and doctor to com-
municate over messaging with each other. Thus, the doctor application can help doc-
tors to monitor his/her patient on social network and empower them to help patients 
to report the side effects. 
5.4 Artifact 2: Patient Mobile Application (Instantiation) 
Initially, when the user runs the application for the first time, a login screen will be 
displayed. A username and password screen prompts for authentication. The user will 
provide unique username and password for the first time. If the username is correct, 
then the application will store the username on the server. If the patient tweeted about 
a drug side effect, the application gathers the tweet content using Twitter API. The 
API matches keywords in Tweets to those that are pre-stored on the server. If the tweet 
matches, then the application will automatically send a notification prompting the pa-
tient to report the side effect to the doctor. The patient can use the following three 
functions. One function is the “patient profile”, which will allow the patient to enter 
and update his/her demographic information, address and medical record number. An-
other function is “send report” which helps patients report an ADR. In this function, 
the patient will be directed through workflow steps to complete an ADR report in-
cluding patient identity, drug reactions, adverse drug event, drug name, and drug dos-
age. Last function is the “chat with a doctor” which allows doctors and patients to 
engage in a real-time transmission of text-based conversation. Thus, the patient can 
ask the doctor questions about completing the ADR report process, or how to avoid 
dangerous adverse drug reactions. Therefore, the patient application can help the pa-
tient communicate with his/her doctor any time, and to report the side effects easily.     
5.5 Artifact 3: An algorithm to look up and detect side effects in patient tweets 
The algorithm works in both the doctor dashboard application and the patient mo-
bile application. The algorithm runs as a loop to detect patient tweets contains side 
effects that match the list of terms of side effect and drugs’ names that stored previ-
ously on the server. The algorithm runs on the doctor application only when the doctor 
uses “lookup for patients”. The following steps explain the algorithm: 
(a) Algorithm Steps in Doctor Application.  
 
(i) Assumption: It is assumed that the patient posted a tweet that has a side effect 
(Fig.2). For example, if a patient posts a tweet including this text: “I have chest pain 
for 2 days from using XYZ … etc.”, then the application works according to the fol-
lowing algorithm description. 
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(ii) Algorithm description: 
1. The doctor looks up the patient username (Fig.1 and Fig. 2). 
2. The application checks if this username has tweeted about a side effect. 
3. If yes, the application retrieves the tweet content using Twitter API. 
4. The application compares the KeywordMatch with tweet content with side ef-
fects that are pre-stored in the server. 
5. If keyword is matching, then a message is sent to the doctor about side effect 
(Fig.1 and Fig. 2). 
6. The doctor sends SMS to patient to download the app. 
(iii) Pseudo code explain the algorithm in doctor application: 
{     SET         initial username 
    IF (username == True) THEN { get Tweet_Content from Twitter API 
         IF (Tweet_Content == True)) 
 THEN   { KeywordMatch ==  Tweet_Content 
            Run_Function (Send SMS)     } 
         ELSE REPEAT } 
    ELSE     END } 
(b) Algorithm Steps in Patient Application.  
 
(i) Assumption: It is assumed that the patient is using his/her Twitter account 
using Twitter on desktop, or Twitter app on a smart device. 
 
(ii) Algorithm description: 
1. After the user logs into the mobile application, the application checks the 
username. (The application stores the username on the server when the user uses the 
patient application for the first time). 
2. The application monitors tweet content that is posted on the user account 
(Fig.1 and Fig. 2). 
3. The application gets the patient tweet content using Twitter API. (Works as a 
repeated process each time of tweet). 
4. The application compares keywords of tweet content to side effects that are 
pre-stored on server. 
5. If KeywordMatch matches one of side effect that pre-stored on server. 
6. Then automatically send a push notification to patient (Fig.1 and Fig. 2). 
7. Patient will use the mobile app to report his/her side effect. 
8. Doctor will receive the report (Fig.1 and Fig. 2). 
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(iii) Pseudo code explain the algorithm in patient application: 
{     
    Get username From Server 
    IF (username == True) THEN { get Tweet_Content from Twitter API 
    IF (Tweet_Content == True)) THEN { KeywordMatch == Tweet_Content 
Run_Function (Push_Notification) 
IF Push_Notification == is_open 
 {initiate_Patient_App 
 } 
   } 
ELSE REPEAT 
} 
    ELSE     END 
} 
 
 Fig. 1. Algorithm steps of both doctor application (left) and patient application (right). 
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Fig. 2. Screenshot of both doctor and patient applications. 
6 Novelty and Advantages 
The artifact, EZ-R is a reporting application that will rely on Twitter and works as a 
mediating solution that will fulfills the FDA’s criteria and helps alleviate the current 
process limitations. EZ-R helps the user to ADR reporting in real time after he/she 
posts a tweet. In addition to the uniqueness of using EZ-R application, it also has two 
advantages. These advantages are: first, it creates an active channel between the pa-
tient and his/her doctor. Second, obtains the four information to validate an ADR re-
port assigned by the FDA. On the other hand, EZ-R is a different solution from the 
data mining or machine learning solutions because data mining and machine learning 
solutions are required a huge amount of data that need data cleansing which can be 
time-consuming, costly, and require special data analytical skills [10]. Moreover, data 
mining and machine learning solutions don’t provide a communication tool between 
the patient and the health professionals in terms of reporting ADRs from Twitter.  
7 Limitation and Challenges 
For this pilot study, the researchers examined the functionality of the application, 
however, there were some challenges and limitations. First, the researchers were lim-
ited in detecting false-positives to detect synonyms of symptoms of the side effect that 
not stored. Second, there remains a limitation in regard of misspelled words, unknown 
keywords, or incorrect drug names submitted by patients and were not previously 
stored on the server.  
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8 Conclusion and Future Work 
Recently, a large number of patients discuss their health issues and ADRs on different 
social networks [18], such as Twitter, which leave a large percentage of ADRs not 
reported to authorize health professionals or to the Food and Drug Administration 
(FDA) [18]. So far there is no reliable tool that might be used by health professionals 
to report an ADR based on their patient’s tweets. This research provides a reliable 
solution that targeted patients whom discussing their current health condition on Twit-
ter, and facilitates the submission of ADR by improving the communication with their 
health care professionals more easy and user-friendly.  
 
Future enhancement should take into account the aforementioned limitations, as well 
as provide a sufficient sample size for the evaluation. Moreover, this solution might 
incorporate video conferencing within the application. More importantly, the applica-
tion can be connected with the FDA database. Also, this solution could be integrated 
with other technologies, such as WordNet, to detect unknown symptoms or unidenti-
fiable patients from different social networks. Lastly, a proper HIPPA and security 
procedures should be implemented to deal with patient’s data privacy.  
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